BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30518149)

  • 1. Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib).
    Bittenbinder MA; Zdenek CN; Op den Brouw B; Youngman NJ; Dobson JS; Naude A; Vonk FJ; Fry BG
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30518149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (
    Chowdhury A; Lewin MR; Zdenek CN; Carter R; Fry BG
    Front Immunol; 2021; 12():752442. PubMed ID: 34691069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mud in the blood: Novel potent anticoagulant coagulotoxicity in the venoms of the Australian elapid snake genus Denisonia (mud adders) and relative antivenom efficacy.
    Youngman NJ; Zdenek CN; Dobson JS; Bittenbinder MA; Gillett A; Hamilton B; Dunstan N; Allen L; Veary A; Veary E; Fry BG
    Toxicol Lett; 2019 Mar; 302():1-6. PubMed ID: 30502385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
    Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varespladib (LY315920) neutralises phospholipase A
    Youngman NJ; Walker A; Naude A; Coster K; Sundman E; Fry BG
    Comp Biochem Physiol C Toxicol Pharmacol; 2020 Oct; 236():108818. PubMed ID: 32512199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib.
    Arrahman A; Kazandjian TD; Still KBM; Slagboom J; Somsen GW; Vonk FJ; Casewell NR; Kool J
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant Micrurus venoms: Targets and neutralization.
    Dashevsky D; Bénard-Valle M; Neri-Castro E; Youngman NJ; Zdenek CN; Alagón A; Portes-Junior JA; Frank N; Fry BG
    Toxicol Lett; 2021 Feb; 337():91-97. PubMed ID: 33197555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant Activity of
    Kazandjian TD; Arrahman A; Still KBM; Somsen GW; Vonk FJ; Casewell NR; Wilkinson MC; Kool J
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of differential antivenom efficacy in neutralising coagulotoxicity produced by venoms from species within the arboreal viperid snake genus Trimeresurus.
    Debono J; Bos MHA; Frank N; Fry B
    Toxicol Lett; 2019 Nov; 316():35-48. PubMed ID: 31509773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative venomics and preclinical efficacy evaluation of a monospecific Hemachatus antivenom towards sub-Saharan Africa cobra venoms.
    Sánchez A; Segura Á; Pla D; Munuera J; Villalta M; Quesada-Bernat S; Chavarría D; Herrera M; Gutiérrez JM; León G; Calvete JJ; Vargas M
    J Proteomics; 2021 May; 240():104196. PubMed ID: 33775842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.
    Zdenek CN; Hay C; Arbuckle K; Jackson TNW; Bos MHA; Op den Brouw B; Debono J; Allen L; Dunstan N; Morley T; Herrera M; Gutiérrez JM; Williams DJ; Fry BG
    Toxicol In Vitro; 2019 Aug; 58():97-109. PubMed ID: 30910521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: Mechanisms, potency, and antivenom efficacy.
    Zdenek CN; Youngman NJ; Hay C; Dobson J; Dunstan N; Allen L; Milanovic L; Fry BG
    Toxicol Lett; 2020 May; 330():176-184. PubMed ID: 32442717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Antivenom and Small-Molecule Inhibition of Novel Coagulotoxic Variations in
    Jones L; Youngman NJ; Neri-Castro E; Guadarrama-Martínez A; Lewin MR; Carter R; Frank N; Fry BG
    Toxins (Basel); 2022 Jul; 14(8):. PubMed ID: 35893753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of ontogenetic differences in the coagulotoxic activity of Bothrops jararacussu venoms.
    Rodrigues CFB; Zdenek CN; Bourke LA; Seneci L; Chowdhury A; Freitas-de-Sousa LA; de Alcantara Menezes F; Moura-da-Silva AM; Tanaka-Azevedo AM; Fry BG
    Toxicol Lett; 2021 Sep; 348():59-72. PubMed ID: 34044056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.
    Lewin M; Samuel S; Merkel J; Bickler P
    Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27571102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib.
    Bartlett KE; Hall SR; Rasmussen SA; Crittenden E; Dawson CA; Albulescu LO; Laprade W; Harrison RA; Saviola AJ; Modahl CM; Jenkins TP; Wilkinson MC; Gutiérrez JM; Casewell NR
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315597121. PubMed ID: 38687786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential destructive (non-clotting) fibrinogenolytic activity in Afro-Asian elapid snake venoms and the links to defensive hooding behavior.
    Bittenbinder MA; Dobson JS; Zdenek CN; Op den Brouw B; Naude A; Vonk FJ; Fry BG
    Toxicol In Vitro; 2019 Oct; 60():330-335. PubMed ID: 31170449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
    Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B
    Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor X activating Atractaspis snake venoms and the relative coagulotoxicity neutralising efficacy of African antivenoms.
    Oulion B; Dobson JS; Zdenek CN; Arbuckle K; Lister C; Coimbra FCP; Op den Brouw B; Debono J; Rogalski A; Violette A; Fourmy R; Frank N; Fry BG
    Toxicol Lett; 2018 May; 288():119-128. PubMed ID: 29462691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-American Lancehead Pit-Vipers: Coagulotoxic Venom Effects and Antivenom Neutralisation of
    Bourke LA; Zdenek CN; Neri-Castro E; Bénard-Valle M; Alagón A; Gutiérrez JM; Sanchez EF; Aldridge M; Fry BG
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.